Codiak BioSciences, Inc. Annual Operating Income (Loss) in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Codiak BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2021.
  • Codiak BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$21.4M, a 0.47% increase year-over-year.
  • Codiak BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$53.3M, a 24.4% increase year-over-year.
  • Codiak BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$69.5M, a 23.5% increase from 2020.
  • Codiak BioSciences, Inc. annual Operating Income (Loss) for 2020 was -$90.9M, a 13.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$69.5M +$21.4M +23.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-10
2020 -$90.9M -$10.8M -13.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$80.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.